Approximately 97% of patients with FOP have an R206H mutation in the gene activin A receptor type I (ACVR1; also known as activin-like kinase 2 [ALK2]) [3–5]. The gene discussed is ACVR1; the disease is fibrodysplasia ossificans progressiva.